Previous research has revealed that KIF2C is substantially expressed in liver cancer (17, 19, 26, 27), breast cancer (28), endometrial carcinoma (20), lung cancer (29, 30), glioma (31), bladder cancer (32), colorectal cancer (33), esophageal squamous cell carcinoma (34), cervical cancer (18), and thyroid cancer (35). Here, KIF2C is linked to breast cancer.